AU2003229437A8 - Use of lanthanum for the treatment of hypercalcemia and bone metastasis - Google Patents
Use of lanthanum for the treatment of hypercalcemia and bone metastasisInfo
- Publication number
- AU2003229437A8 AU2003229437A8 AU2003229437A AU2003229437A AU2003229437A8 AU 2003229437 A8 AU2003229437 A8 AU 2003229437A8 AU 2003229437 A AU2003229437 A AU 2003229437A AU 2003229437 A AU2003229437 A AU 2003229437A AU 2003229437 A8 AU2003229437 A8 AU 2003229437A8
- Authority
- AU
- Australia
- Prior art keywords
- hypercalcemia
- lanthanum
- treatment
- bone metastasis
- metastasis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/244—Lanthanides; Compounds thereof
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37840102P | 2002-05-08 | 2002-05-08 | |
US60/378,401 | 2002-05-08 | ||
PCT/CA2003/000684 WO2003094933A2 (en) | 2002-05-08 | 2003-05-08 | Use of lanthanum for the treatment of hypercalcemia and bone metastasis |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003229437A1 AU2003229437A1 (en) | 2003-11-11 |
AU2003229437A8 true AU2003229437A8 (en) | 2003-11-11 |
Family
ID=29420395
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003229437A Abandoned AU2003229437A1 (en) | 2002-05-08 | 2003-05-08 | Use of lanthanum for the treatment of hypercalcemia and bone metastasis |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003229437A1 (en) |
WO (1) | WO2003094933A2 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060083791A1 (en) | 2002-05-24 | 2006-04-20 | Moerck Rudi E | Rare earth metal compounds methods of making, and methods of using the same |
US20040161474A1 (en) | 2002-05-24 | 2004-08-19 | Moerck Rudi E. | Rare earth metal compounds methods of making, and methods of using the same |
US7465465B2 (en) * | 2003-08-26 | 2008-12-16 | Shire Biochem Inc. | Pharmaceutical formulation comprising lanthanum compounds |
US7381428B2 (en) | 2003-08-26 | 2008-06-03 | Shire International Licensing B.V. | Stabilized lanthanum carbonate compositions |
CA2574450C (en) * | 2004-07-27 | 2011-07-19 | Shire Pharmaceuticals, Inc. | Method of treating hyperphosphataemia using lanthanum hydroxycarbonate |
US20060134225A1 (en) * | 2004-10-15 | 2006-06-22 | Moerck Rudi E | Phosphate binder with reduced pill burden |
US7862836B2 (en) * | 2005-04-12 | 2011-01-04 | Biolink Life Sciences, Inc. | Phosphorus binder for treatment of kidney disease |
EP1928349A4 (en) * | 2005-08-17 | 2008-10-01 | Altairnano Inc | Treatment of chronic renal failure and other conditions in domestic animals: compositions and methods |
TWI446916B (en) | 2010-05-12 | 2014-08-01 | Spectrum Pharmaceuticals Inc | Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use |
CN103127041A (en) * | 2012-02-23 | 2013-06-05 | 南京卡文迪许生物工程技术有限公司 | Medicinal composition with lanthanum acetate, preparation method and application thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9506126D0 (en) * | 1995-03-25 | 1995-05-10 | Johnson Matthey Plc | Pharmaceutical composition and method |
GB0015745D0 (en) * | 2000-06-27 | 2000-08-16 | Shire Holdings Ag | Treatment of bone diseases |
-
2003
- 2003-05-08 AU AU2003229437A patent/AU2003229437A1/en not_active Abandoned
- 2003-05-08 WO PCT/CA2003/000684 patent/WO2003094933A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2003229437A1 (en) | 2003-11-11 |
WO2003094933A2 (en) | 2003-11-20 |
WO2003094933A3 (en) | 2004-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003228445A8 (en) | Tissue composites and uses thereof | |
PT2702871T (en) | Collagen biofabric and use thereof | |
EP1539941A4 (en) | Adzymes and uses thereof | |
HK1061212A1 (en) | Pyranoindazoles and their use for the treatment ofglaucoma | |
TWI347188B (en) | Treatment and prevention of osteoporosis | |
PL358848A1 (en) | Bone treatment material | |
GB0220214D0 (en) | Compounds and their use | |
GB2413966B (en) | Foot and hand treatment system | |
AU2003229437A8 (en) | Use of lanthanum for the treatment of hypercalcemia and bone metastasis | |
GB0213869D0 (en) | The treatment of pain | |
IL165112A0 (en) | Variant integrinpolypeptides and thereof | |
AU2003231827A8 (en) | Pseudo-tissues and uses thereof | |
GB0227906D0 (en) | Compounds and their use | |
AU2003224348A8 (en) | Bone densitometry and mammography | |
GB0230134D0 (en) | Compounds and their use | |
AU2003228397A8 (en) | Hausp-p53 interaction and uses thereof | |
AU2003273817A8 (en) | Increasing of the resorption of substances via skin and mucous membranes | |
GB0230281D0 (en) | Compounds and their use | |
GB0317864D0 (en) | Compounds and their use | |
AU2003216442A8 (en) | Enkurin and uses thereof | |
GB0329357D0 (en) | Treatment of materials | |
GB0224146D0 (en) | Skin treatment materials | |
GB0212208D0 (en) | Skin treatment materials | |
GB0220215D0 (en) | Compounds and their use | |
GB0221954D0 (en) | Compounds and their medical uses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase | ||
TH | Corrigenda |
Free format text: IN VOL 18, NO 2, PAGE(S) 584 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME SHIRE HOLDING AG , APPLICATION NO. 2003229437, UNDER INID (43) CORRECT THE PUBLICATION DATE TO READ 24.11.2003 |